Volume 7, Issue 3 (Summer 2019)                   Iran J Health Sci 2019, 7(3): 42-50 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yazdani Charati J, Hosseinnataj A, Vahedi M, Abdollahi F. Epidemiological Study of Tuberculosis in Northern Iran. Iran J Health Sci. 2019; 7 (3) :42-50
URL: http://jhs.mazums.ac.ir/article-1-651-en.html
Mazandaran University of Medical Sciences, Sari, Iran , abdollahizagh@gmail.com
Abstract:   (553 Views)
Background & Purpose:  One of the most important united nation Millennium Development Goals is to control Tuberculosis (TB). This study aimed to identify the high-risk areas of TB and other related factors of it in an epidemiological study.
Materials & Methods:  In this retrospective study, the records of 1566 TB infected patients in healthcare centers of 17 cities of Mazandaran University of Medical Sciences were investigated during 2009-2013 years. Information of patients was gathered using a check list. The collected data was then analyzed using chi-square.
Results: The mean age of the patients was 46.17± 20.6 years. The 5-year incidence rate was 12.14 in 100,000 populations. Cities in the east of Province (Sari, Behshahr, and Neka) had highest incidence rate (about 16 cases in 100,000 population). The incidence rate was different based on gender as, 15.3 % of the men and 10.2 % of the women were infected. The median delay time in the diagnosis was 34 days.
Conclusions: The incidence rate of TB in Mazandaran was found to be almost similar to the previous reported rate in Iran. High incidence rate in east of province may be due to bordering to the Golestan Province as the immigrant province. The short delay time of TB diagnosis during this period indicated the well health services practices in this province. More attention should be paid to high risk areas for identification and giving education to those patients.
Full-Text [PDF 618 kb]   (308 Downloads)    
Type of Study: Original Article | Subject: Environmental Health

1. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007;370(9603):1929-38. [DOI:10.1016/S0140-6736(07)61696-1]
2. Choi H, Lee M, Chen RY, Kim Y, Yoon S, Joh JS, et al. Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012. BMC Infectious Diseases. 2014;14(1):360. [DOI:10.1186/1471-2334-14-360] [PMID] [PMCID]
3. CHang KC, YEW WW. Management of difficult multidrug‐resistant tuberculosis and extensively drug‐resistant tuberculosis: update 2012. Respirology. 2013;18(1):8-21. [DOI:10.1111/j.1440-1843.2012.02257.x] [PMID]
4. Hatami H, Razavi S, Eftekhar H, Majlesi F. Comprehensive book of public health. Tehran: Arjemand Publications. 2007:45-7.
5. Organization WH. Global tuberculosis report 2013: World Health Organization; 2013. Book
6. Soria J, Metcalf T, Mori N, Newby RE, Montano SM, Huaroto L, et al. Mortality in hospitalized patients with tuberculous meningitis. BMC Infectious Diseases. 2019;19(1):9. [DOI:10.1186/s12879-018-3633-4] [PMID] [PMCID]
7. Hassan Zadeh J, Nasehi M, Rezaianzadeh A, Tabatabaee H, Rajaeifard A, Ghaderi E. Pattern of reported tuberculosis cases in iran 2009-2010. Iranian journal of public health. 2013;42(1):72-8.
8. Organization WH. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009: World Health Organization; 2009. Book
9. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. The New England journal of medicine. 1989; 320(9):545-50. [DOI:10.1056/NEJM198903023200901] [PMID]
10. Shamu S, Kuwanda L, Farirai T, Guloba G, Slabbert J, Nkhwashu N. Study on knowledge about associated factors of Tuberculosis (TB) and TB/HIV co-infection among young adults in two districts of South Africa. PloS one. 2019;14(6):e0217836. 10.1371/journal.pone.0217836. [DOI:10.1371/journal.pone.0217836] [PMID] [PMCID]
11. MacNeil A, Glaziou P, Sismanidis C, Maloney S, Floyd K. Global Epidemiology of Tuberculosis and Progress Toward Achieving Global Targets - 2017. MMWR Morb Mortal Wkly Rep. 2019;68(11):263-6. [DOI:10.15585/mmwr.mm6811a3] [PMID] [PMCID]
12. Yazdani-Chrati J, Mrdanshah F, Etemadi-Nejad S, Rezaei M-S, Ghadami M, Ahmadi-Baseri E. Application of empirical Bayes smoothed incidence rates of tuberculosis during the year 2005-2011 to prepare geographical map of tuberculosis incidence. Journal of Mazandaran University of Medical Sciences. 2014;23(110):45-56.
13. Ebrahimzadeh A, Sharifzadeh GR, Eshaghi S. The epidemiology of Tuberculosis in Birjand (1996-2006). Journal of Birjand University of Medical Sciences. 2009;16(1):31-8.
14. Najafzadeh H, Ghorbani K. Epidemiology of tuberculosis in a health center in Rasht city in 86 years. 5th National Congress of Tuberculosis 2009.
15. Organization WH. Global Tuberculosis Report. Geneva: World Health Organization; 2014. 2016.
16. Martinez AN, Rhee JT, Small PM, Behr MA. Sex differences in the epidemiology of tuberculosis in San Francisco. International Journal of Tuberculosis and Lung Disease. 2000;4(1):26-31.
17. Amani F, Bashiri J, Sabzevari A, Gharoosi B, Nahanmoghaddam N. Epidemiology of Tuberculosis in Ardabil, 2001-2005. Journal of Ardabil University of Medical Sciences. 2007;7(3):236-341.
18. Yazdani Charati J, Kazemnejad A, Mosazadeh M. An epidemiological study on the reported cases of tuberculosis in Mazandaran (1999-2008) using spatial design. Journal of Mazandaran University of Medical Sciences. 2010;19(74):9-16.
19. Nili S, Karimi M, Banafshi O. Epidemiologic study of extrapulmonary TB in kurdistan 2007-2009. 19 th Iranian congress on infectious diseases and tropical medicine 2010; Iran2010. p. 138.
20. Mohamadi Azni S, Mansourian AA, Nokandeh Z. Epidemiological study of tuberculosis in Damghan city (Iran) during 2003-2007. koomesh. 2008;9(4):315-20.
21. Abbasi A, Arabi M. Efficiency of Dots strategy in Recovery or reverse of tuberculosis Patient. Journal of Gorgan Medical Science university. 2004;6(13):78-84.
22. Najafzadeh H, Ghorbani K, Sedighi A, Asadi S, Rezaee A. Epidemiologic study of tuberculosis in a health center in Rasht city in 2007. 19th National Congress of tuberculosis; Zanjan, Iran2008. p. 20.
23. Tavakoli A. Incidence and Prevalence of Tuberculosis in Iran and Neighboring Countries. Zahedan Journal of Research in Medical Sciences 2017;19(7):e9238. [DOI:10.5812/zjrms.9238]
24. Rajeswari R, Balasubramanian R, Muniyandi M, Geetharamani S, Thresa X, Venkatesan P. Socio-economic impact of tuberculosis on patients and family in India. The international journal of tuberculosis and lung disease. 1999;3(10):869-77.
25. Hazrati S, Khaligh N, Moeini A, Amani F, Barak M, Rahimi G, et al. Epidemiology of Tuberculosis in Ardabil City from 2005 to 2010. Journal of Health. 2013;4(2):103-9.
26. WHO. World Health organization global tuberculosis: Tuberculosis 2018 [Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis.
27. Rajagopalan S, Yoshikawa TT. Tuberculosis in the elderly. Zeitschrift fur Gerontologie und Geriatrie. 2000;33(5):374-80. [DOI:10.1007/s003910070034] [PMID]
28. Caylà JA, Orcau A. Control of tuberculosis in large cities in developed countries: an organizational problem. BMC Medicine. 2011;9(1):127. [DOI:10.1186/1741-7015-9-127] [PMID] [PMCID]
29. Owiti P, Onyango D, Momanyi R, Harries AD. Screening and testing for tuberculosis among the HIV-infected: outcomes from a large HIV program in western Kenya. BMC Public Health. 2019;19(1):29-. [DOI:10.1186/s12889-018-6334-4] [PMID] [PMCID]

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | Iranian Journal of Health Sciences

Designed & Developed by : Yektaweb